ARCHIVES

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

This article is from The Cancer Letter archive.

Vol. 31 No. 01 | January 7, 2005

Download PDF Visit The Full Archive

Related Articles

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989